HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mouse strain and source of L-tryptophan affects hepatic nuclear tryptophan binding.

Abstract
This study describes that the affinity for specific L-tryptophan binding to hepatic nuclei in vitro is markedly decreased in NZBWF1 mice in comparison to that in Swiss mice. Also, the hepatic nuclei of NZBWF1 mice have a significantly decreased binding response in vitro to Showa Denko L-tryptophan (implicated in the eosinophilia-myalgia syndrome) or to its contaminants, 1,1'-ethylidenebis(tryptophan) or 3-phenylamino-L-alanine, when each is added to control, non-implicated L-tryptophan compared with hepatic nuclei of Swiss mice. Enhanced hepatic protein synthesis induced by tube-feeding control L-tryptophan is much less in NZBWF1 mice than in Swiss mice. Tube-feeding of Showa Denko L-tryptophan induced less stimulation of hepatic protein synthesis than did control L-tryptophan in Swiss mice but essentially none in NZBWF1 mice. NZBWF1 mice have a genetically altered response to L-tryptophan which may prove to be useful is studying the role of L-tryptophan in health and in disease.
AuthorsH Sidransky, E Verney
JournalToxicology (Toxicology) Vol. 118 Issue 1 Pg. 37-47 (Mar 14 1997) ISSN: 0300-483X [Print] Ireland
PMID9074652 (Publication Type: Comparative Study, Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Selenium Compounds
  • 1,1'-ethylidene bis(tryptophan)
  • 3-(phenylamino)alanine
  • Tryptophan
  • Sodium Selenite
  • Selenic Acid
  • Alanine
Topics
  • Alanine (analogs & derivatives, pharmacology)
  • Animals
  • Binding, Competitive
  • Cell Nucleus (metabolism)
  • Liver (metabolism, ultrastructure)
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred DBA
  • Mice, Inbred NZB
  • Protein Biosynthesis
  • Selenic Acid
  • Selenium Compounds (pharmacology)
  • Sodium Selenite (pharmacology)
  • Tryptophan (analogs & derivatives, chemistry, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: